GlassScriptPhysician profile
John H Sloan
NPI 1922117019
$5,592.76
in general payments reported to CMS, 2019-2025
11 companies · $1,839 in 2025
The $1,839 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.96 · 2021: $88.14 · 2022: $1,197 · 2023: $299 · 2024: $2,149 · 2025: $1,839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,400 · Food and Beverage: $1,887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,399.67 |
| Food and Beverage | $1,886.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $2,640.62 | 2024-2025 | Iovera |
| Nevro Corp. | $1,403.19 | 2022-2024 | Senza |
| Medtronic, INC. | $565.08 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Abbott Laboratories | $420.71 | 2023-2024 | Proclaim |
| Merz Pharmaceuticals, LLC | $164.48 | 2025 | Xeomin |
| Mimedx Group, INC. | $132.50 | 2024 | |
| Abbvie INC. | $105.89 | 2023-2025 | Botox |
| Pfizer INC. | $53.55 | 2020-2021 | |
| Bioventus LLC | $51.19 | 2025 | Durolane |
| Biohaven Pharmaceuticals, INC. | $32.52 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.